EVIDENCE LIBRARY
Perampanel Case Reported Seizure Cessation After a Regimen Including Midazolam Had Been Insufficient
A super-refractory status epilepticus case described improvement after adding perampanel. The treatment sequence was suggestive but did not isolate the new drug’s contribution.
A super-refractory status epilepticus case described improvement after adding perampanel. The treatment sequence was suggestive but did not isolate the new drug’s contribution.
The sequential treatment
After evacuation of a subdural hematoma, an older patient developed persistent focal status epilepticus. Multiple agents, including intravenous midazolam and thiopental, had not achieved sustained control.
Perampanel was administered through a nasogastric tube and increased over a short interval. Clinical and electrical seizures ceased, and other medicines were gradually reduced with a favorable reported outcome.
A case cannot define comparative efficacy
Earlier medicines remained relevant, and delayed treatment effects or changes in the underlying brain injury could contribute. There was no randomized or withdrawal comparison.
The report does not establish that perampanel universally replaces midazolam or provide a general rescue regimen. Forensic interpretation should retain structural injury, EEG documentation, doses actually given, overlap among treatments, and timing of tapering. Clinical response after an addition is different from proof that the preceding medicines had no effect at any stage.
Source paper
Original analysis of the supplied journal article, identified as PMC6481131.